Limited efficacy of daratumumab in multiple myeloma with extramedullary disease
- Resource Type
- Source
- Leukemia. 36:288-291
- Subject
Oncology Cancer Research medicine.medical_specialty business.industry Plasma Cells Antibodies, Monoclonal Daratumumab Antineoplastic Agents Hematology Prognosis medicine.disease Clone Cells Survival Rate Extramedullary disease Novel agents Internal medicine medicine Overall survival Humans Multiple Myeloma business Multiple myeloma Follow-Up Studies Retrospective Studies - Language
- ISSN
- 1476-5551
0887-6924